SARA HERBST: Open Payments
NPI 1790203586 · CHANTILLY, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,041 in 34 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $262 · 2025 $1,041
Food & beverage: $1,041
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $233 |
| Janssen Biotech, Inc. | 4 | $208 |
| Gilead Sciences, Inc. | 1 | $122 |
| Ethicon US, LLC | 1 | $94 |
| Lilly USA, LLC | 2 | $59 |
| Aimmune Therapeutics, Inc. | 3 | $59 |
| Celltrion USA Inc. | 2 | $53 |
| PFIZER INC. | 2 | $49 |
| Ardelyx, Inc. | 2 | $45 |
| Madrigal Pharmaceuticals | 1 | $34 |
Products named: TREMFYA, Livdelzi, RINVOQ, LINX REFLUX MANAGEMENT SYSTEM, OMVOH, ZENPEP, VEGZELMA, CREON.
Industry payments across VA — which companies pay providers there.
